Cholangiocarcinoma (CCA) is biologically heterogeneous, and timely molecular profiling is increasingly critical for treatment selection in unresectable, recurrent, or metastatic disease. Beyond guideline-style summaries, we provide an implementation-oriented f... ...

请注册登录后继续浏览